276 related articles for article (PubMed ID: 15505207)
1. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant.
Torres GE; Sweeney AL; Beaulieu JM; Shashidharan P; Caron MG
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15650-5. PubMed ID: 15505207
[TBL] [Abstract][Full Text] [Related]
2. Recombinant expression, purification, and comparative characterization of torsinA and its torsion dystonia-associated variant Delta E-torsinA.
Kustedjo K; Deechongkit S; Kelly JW; Cravatt BF
Biochemistry; 2003 Dec; 42(51):15333-41. PubMed ID: 14690443
[TBL] [Abstract][Full Text] [Related]
3. Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells.
Misbahuddin A; Placzek MR; Taanman JW; Gschmeissner S; Schiavo G; Cooper JM; Warner TT
Mov Disord; 2005 Apr; 20(4):432-440. PubMed ID: 15593317
[TBL] [Abstract][Full Text] [Related]
4. Chemical enhancement of torsinA function in cell and animal models of torsion dystonia.
Cao S; Hewett JW; Yokoi F; Lu J; Buckley AC; Burdette AJ; Chen P; Nery FC; Li Y; Breakefield XO; Caldwell GA; Caldwell KA
Dis Model Mech; 2010; 3(5-6):386-96. PubMed ID: 20223934
[TBL] [Abstract][Full Text] [Related]
5. The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia.
Zacchi LF; Wu HC; Bell SL; Millen L; Paton AW; Paton JC; Thomas PJ; Zolkiewski M; Brodsky JL
J Biol Chem; 2014 May; 289(18):12727-47. PubMed ID: 24627482
[TBL] [Abstract][Full Text] [Related]
6. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.
Gonzalez-Alegre P; Paulson HL
J Neurosci; 2004 Mar; 24(11):2593-601. PubMed ID: 15028751
[TBL] [Abstract][Full Text] [Related]
7. Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors.
Bragg DC; Camp SM; Kaufman CA; Wilbur JD; Boston H; Schuback DE; Hanson PI; Sena-Esteves M; Breakefield XO
Neuroscience; 2004; 125(3):651-61. PubMed ID: 15099679
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human torsinA and its dystonia-associated mutant form.
Liu Z; Zolkiewska A; Zolkiewski M
Biochem J; 2003 Aug; 374(Pt 1):117-22. PubMed ID: 12780349
[TBL] [Abstract][Full Text] [Related]
9. Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion.
Naismith TV; Dalal S; Hanson PI
J Biol Chem; 2009 Oct; 284(41):27866-27874. PubMed ID: 19651773
[TBL] [Abstract][Full Text] [Related]
10. The dystonia-associated protein torsinA modulates synaptic vesicle recycling.
Granata A; Watson R; Collinson LM; Schiavo G; Warner TT
J Biol Chem; 2008 Mar; 283(12):7568-79. PubMed ID: 18167355
[TBL] [Abstract][Full Text] [Related]
11. Dystonia-associated forms of torsinA are deficient in ATPase activity.
Konakova M; Pulst SM
J Mol Neurosci; 2005; 25(1):105-17. PubMed ID: 15781971
[TBL] [Abstract][Full Text] [Related]
12. Molecular defects of the dystonia-causing torsinA mutation.
Pham P; Frei KP; Woo W; Truong DD
Neuroreport; 2006 Nov; 17(16):1725-8. PubMed ID: 17047461
[TBL] [Abstract][Full Text] [Related]
13. Miniature release events of glutamate from hippocampal neurons are influenced by the dystonia-associated protein torsinA.
Kakazu Y; Koh JY; Iwabuchi S; Gonzalez-Alegre P; Harata NC
Synapse; 2012 Sep; 66(9):807-22. PubMed ID: 22588999
[TBL] [Abstract][Full Text] [Related]
14. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics.
Hewett JW; Zeng J; Niland BP; Bragg DC; Breakefield XO
Neurobiol Dis; 2006 Apr; 22(1):98-111. PubMed ID: 16361107
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA.
Bragg DC; Kaufman CA; Kock N; Breakefield XO
Mol Cell Neurosci; 2004 Dec; 27(4):417-26. PubMed ID: 15555920
[TBL] [Abstract][Full Text] [Related]
16. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.
Goodchild RE; Dauer WT
Proc Natl Acad Sci U S A; 2004 Jan; 101(3):847-52. PubMed ID: 14711988
[TBL] [Abstract][Full Text] [Related]
17. Dopamine release is impaired in a mouse model of DYT1 dystonia.
Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG
J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.
Hettich J; Ryan SD; de Souza ON; Saraiva Macedo Timmers LF; Tsai S; Atai NA; da Hora CC; Zhang X; Kothary R; Snapp E; Ericsson M; Grundmann K; Breakefield XO; Nery FC
Hum Mutat; 2014 Sep; 35(9):1101-13. PubMed ID: 24930953
[TBL] [Abstract][Full Text] [Related]
19. Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE.
Zacchi LF; Dittmar JC; Mihalevic MJ; Shewan AM; Schulz BL; Brodsky JL; Bernstein KA
Dis Model Mech; 2017 Sep; 10(9):1129-1140. PubMed ID: 28768697
[TBL] [Abstract][Full Text] [Related]
20. Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations.
Kustedjo K; Bracey MH; Cravatt BF
J Biol Chem; 2000 Sep; 275(36):27933-9. PubMed ID: 10871631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
